+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID06745102

Study of Hop Compounds Xanthohumol and Iso-alpha Acids on Immune Response in Overweight Adults With Early Metabolic Conditions

Led by University of Vienna · Updated on 2025-04-15

24

Participants Needed

1

Research Sites

12 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of Iso-alpha Acids and Xanthohumol, compounds from hops, on the immune response in overweight people who may have early metabolic diseases such as pre-diabetes, fatty liver, or mild high blood pressure. The study aims to understand how these compounds influence immune-related markers in isolated blood cells and whether their levels differ from those in normal-weight individuals. Participants are randomly assigned to receive a study drink containing either Xanthohumol, Iso-alpha Acids, or a combination of both, with some receiving a placebo version without the active compounds. The drink and a light breakfast must be consumed within 15 minutes. Blood samples are collected before intake and at 1, 2, 3, 4, and 6 hours after to measure clinical parameters, blood lipids, glucose, uric acid, inflammatory markers, and immune response in stimulated blood cells. During the study, participants provide fasting blood samples and follow up with multiple blood draws over six hours after consuming the study drink. Researchers monitor changes in immune response parameters as the main outcome. The total participation involves these blood assessments and monitoring of metabolic and inflammatory markers to evaluate the effects of the hop compounds on the immune system.

CONDITIONS

Brief Title

Hop Compounds on the Immune System in Overweight People

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here